What is the Projected CAGR value of the Celiac Disease Drugs Market?
Celiac Disease Drugs Market is expected to grow at a CAGR of 8.28% during the forecasting period 2023-2030.
Which region controlled the global market during 2023-2030?
North America region Controls the Celiac Disease Drugs Market during 2023-2030.
Which is the fastest growing region in the Celiac Disease Drugs Market?
Among all regions, Asia Pacific is the fastest growing market share during the forecast period.
Who are the key players in Celiac Disease Drugs Market?
Major players are Innovate Biopharmaceuticals, Teva Pharmaceutical Industries Ltd, ImmunogenX, LLC, Amgen, ChemoCentryx, Inc, Anokion SA, COUR Pharmaceutical, F. Hoffmann-La Roche Ltd, ImmusanT, Inc, BioLineRx Ltd, and Takeda Pharmaceutical Company Limited, among others.